BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20402410)

  • 1. The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.
    Li S; Bozzo L; Wu Z; Lu W; Romerio F
    New Microbiol; 2010 Jan; 33(1):13-24. PubMed ID: 20402410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis.
    Dolcetti R; Giagulli C; He W; Selleri M; Caccuri F; Eyzaguirre LM; Mazzuca P; Corbellini S; Campilongo F; Marsico S; Giombini E; Muraro E; Rozera G; De Paoli P; Carbone A; Capobianchi MR; Ippolito G; Fiorentini S; Blattner WA; Lu W; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14331-6. PubMed ID: 26578780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of HIV-1 matrix protein p17 and association with B-cell lymphoma in HIV-1 transgenic mice.
    Carroll VA; Lafferty MK; Marchionni L; Bryant JL; Gallo RC; Garzino-Demo A
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13168-13173. PubMed ID: 27799525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient.
    Caccuri F; Muraro E; Gloghini A; Turriziani O; Riminucci M; Giagulli C; Mastorci K; Fae' DA; Fiorentini S; Caruso A; Carbone A; Dolcetti R
    Hematol Oncol; 2019 Apr; 37(2):176-184. PubMed ID: 30261551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.
    Giagulli C; Marsico S; Magiera AK; Bruno R; Caccuri F; Barone I; Fiorentini S; Andò S; Caruso A
    PLoS One; 2011 Mar; 6(3):e17831. PubMed ID: 21423810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian immunodeficiency virus and human immunodeficiency virus type 1 matrix proteins specify different capabilities to modulate B cell growth.
    Caccuri F; Giagulli C; Reichelt J; Martorelli D; Marsico S; Bugatti A; Barone I; Rusnati M; Guzman CA; Dolcetti R; Caruso A
    J Virol; 2014 May; 88(10):5706-17. PubMed ID: 24623414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HIV matrix protein p17 promotes the activation of human hepatic stellate cells through interactions with CXCR2 and Syndecan-2.
    Renga B; Francisci D; Schiaroli E; Carino A; Cipriani S; D'Amore C; Sidoni A; Sordo RD; Ferri I; Lucattelli M; Lunghi B; Baldelli F; Fiorucci S
    PLoS One; 2014; 9(4):e94798. PubMed ID: 24736615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma.
    Selleri M; Dolcetti R; Caccuri F; Giombini E; Rozera G; Abbate I; Mammone A; Zanussi S; Martorelli D; Fiorentini S; Caruso A; Capobianchi MR
    New Microbiol; 2017 Jan; 40(1):58-61. PubMed ID: 28072889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
    Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 Matrix Protein p17 and its Receptors.
    Caccuri F; Marsico S; Fiorentini S; Caruso A; Giagulli C
    Curr Drug Targets; 2016; 17(1):23-32. PubMed ID: 26302809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
    Giagulli C; D'Ursi P; He W; Zorzan S; Caccuri F; Varney K; Orro A; Marsico S; Otjacques B; Laudanna C; Milanesi L; Dolcetti R; Fiorentini S; Lu W; Caruso A
    Sci Rep; 2017 Jul; 7(1):6555. PubMed ID: 28747658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
    Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
    J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3β axis under nutrient starvation.
    Lu J; Jia J; Zhang J; Liu X
    J Med Virol; 2021 Jun; 93(6):3607-3620. PubMed ID: 32790080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
    Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
    Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 p17 matrix protein interacts with heparan sulfate side chain of CD44v3, syndecan-2, and syndecan-4 proteoglycans expressed on human activated CD4+ T cells affecting tumor necrosis factor alpha and interleukin 2 production.
    De Francesco MA; Baronio M; Poiesi C
    J Biol Chem; 2011 Jun; 286(22):19541-8. PubMed ID: 21482826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
    Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A
    Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.
    Caccuri F; Giagulli C; Bugatti A; Benetti A; Alessandri G; Ribatti D; Marsico S; Apostoli P; Slevin MA; Rusnati M; Guzman CA; Fiorentini S; Caruso A
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14580-5. PubMed ID: 22904195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1.
    Marini E; Tiberio L; Caracciolo S; Tosti G; Guzman CA; Schiaffonati L; Fiorentini S; Caruso A
    Cell Microbiol; 2008 Mar; 10(3):655-66. PubMed ID: 18042260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.